About AVT
Browse Articles
Customer Services

Current Issue

Displaying 11 results:

Original article

Combining corticosteroids and acyclovir in the management of varicella pneumonia: a prospective study

Shaikh Khurshid Anwar, Ibrahim Masoodi, Abdulaziz Alfaifi, Shabnum Hussain, Irshad A Sirwal

Antiviral Therapy 2014; 19:221-224

Original article

Analysis of hepatitis C viral kinetics during administration of two nucleotide analogues: sofosbuvir (GS-7977) and GS-0938

Jeremie Guedj, Phillip S Pang, Jill Denning, Maribel Rodriguez-Torres, Eric Lawitz, William Symonds, Alan S Perelson

Antiviral Therapy 2014; 19:211-220

Original article

Slow response to entecavir treatment in treatment-naive HBV patients is conditioned by immune response rather than by the presence or selection of refractory variants

Mariacarmela Solmone, Emanuela Giombini, Donatella Vincenti, Gabriella Rozera, Angela Testa, Alessandra Moscetti, Manuela Catalano, Isabella Abbate, Maria R Capobianchi, Stefano Menzo

Antiviral Therapy 2014; 19:201-209

Original article

Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO)

David A Wohl, Chloe Orkin, Manuela Doroana, José H Pilotto, Somnuek Sungkanuparph, Patrick Yeni, Simon Vanveggel, Henri Deckx, Katia Boven

Antiviral Therapy 2014; 19:191-200

Original article

Delayed emergence of HIV-1 variants resistant to 4′-ethynyl-2-fluoro-2′-deoxyadenosine: comparative sequential passage study with lamivudine, tenofovir, emtricitabine and BMS-986001

Kenji Maeda, Darshan V Desai, Manabu Aoki, Hirotomo Nakata, Eiichi N Kodama, Hiroaki Mitsuya

Antiviral Therapy 2014; 19:179-189

Original article

Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV–HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort

Perrine Roux, Caroline Lions, Julien Cohen, Maria Winnock, Dominique Salmon-Céron, Firouze Bani-Sadr, Philippe Sogni, Bruno Spire, François Dabis, Maria Patrizia Carrieri, the ANRS-CO13-HEPAVIH Study Group

Antiviral Therapy 2014; 19:171-178

Original article

Changes to antiretroviral drug regimens during integrated TB–HIV treatment: results of the SAPiT trial

Anushka Naidoo, Kogieleum Naidoo, Nonhlanhla Yende-Zuma, Tanuja N Gengiah, Nesri Padayatchi, Andrew L Gray, Sheila Bamber, Gonasagrie Nair, Salim S Abdool Karim

Antiviral Therapy 2014; 19:161-169

Original article

Changes in biomarkers of liver disease during successful combination antiretroviral therapy in HIV–HCV-coinfected individuals

Janine Rohrbach, Felix Stickel, Patrick Schmid, Wolfgang Thormann, Helen Kovari, Alexandra Scherrer, Huldrych F Günthard, Danielle Vuichard, Matthias Cavassini, Juan Ambrosioni, Enos Bernasconi, Hansjakob Furrer, Andri Rauch, the Swiss HIV Cohort Study

Antiviral Therapy 2014; 19:149-159

Original article

Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study

David A Wohl, Gretchen Arnoczy, Carl J Fichtenbaum, Thomas Campbell, Babafemi Taiwo, Charles Hicks, Grace A McComsey, Susan Koletar, Paul Sax, Pablo Tebas, Belinda Ha, Kelly Massengale, Kendall Walsh, James H Stein

Antiviral Therapy 2014; 19:141-147


A systematic review on the role of adjunctive corticosteroids in herpes simplex virus encephalitis: is timing critical for safety and efficacy?

Ciro Ramos-Estebanez, Karlo J Lizarraga, Amedeo Merenda

Antiviral Therapy 2014; 19:133-139

Copyright © Nucleus Global 2014. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.